News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), has announced a new strategic partnership with ADC Biotechnology, a UK based company specializing in antibody-drug conjugates (ADCs).
Thermo Fisher Scientific today announced the construction of a new cGMP plasmid DNA manufacturing facility at its site in Carlsbad, California.
The US Food and Drug Administration (FDA), in a review of Moderna’s COVID-19 vaccine candidate, found no safety concerns that would preclude the granting of emergency use authorization (EUA) for the vaccine in the US during the pandemic.